Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-EN
Language French English
Date Updated 2017-03-13 2017-03-13
Drug Identification Number 00466409 00466409
Brand name PULMOPHYLLINE ELX PULMOPHYLLINE ELX
Common or Proper name Theophylline oral solution USP Theophylline oral solution USP
Company Name LABORATOIRE RIVA INC. LABORATOIRE RIVA INC.
Ingredients THEOPHYLLINE THEOPHYLLINE
Strength(s) 80MG 80MG
Dosage form(s) ELIXIR ELIXIR
Route of administration ORAL ORAL
Packaging size 1 1
ATC code R03DA R03DA
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2014-04-11 2014-04-11
Actual start date 2014-04-11 2014-04-11
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments